BSX – Boston Scientific Corporation

BSX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.94

Margin Of Safety %

Put/Call OI Ratio

0.35

EPS Next Q Diff

0.05

EPS Last/This Y

0.32

EPS This/Next Y

0.38

Price

57.78

Target Price

83.73

Analyst Recom

1.31

Performance Q

-22.35

Upside

-9.3%

Beta

0.62

Ticker: BSX

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-24	BSX	62.06	0.64	1.03	322058
2026-04-27	BSX	59.94	0.56	0.42	280380
2026-04-28	BSX	58.44	0.56	0.45	286564
2026-04-29	BSX	57.08	0.56	1.00	293303
2026-04-30	BSX	57.61	0.55	1.59	299786
2026-05-01	BSX	56.59	0.51	0.88	305117
2026-05-04	BSX	56.85	0.51	0.11	302146
2026-05-05	BSX	55.95	0.49	0.39	315250
2026-05-06	BSX	56.01	0.45	0.72	311411
2026-05-07	BSX	56.58	0.44	2.21	317063
2026-05-08	BSX	53.93	0.43	0.31	318756
2026-05-11	BSX	53.38	0.33	0.75	384958
2026-05-12	BSX	54.13	0.33	0.32	397432
2026-05-13	BSX	53.06	0.31	0.88	405726
2026-05-14	BSX	53.56	0.32	0.93	411704
2026-05-15	BSX	52.67	0.31	0.86	422048
2026-05-18	BSX	55.94	0.34	0.57	383567
2026-05-19	BSX	56.83	0.36	0.28	397707
2026-05-20	BSX	56.68	0.35	0.23	406307
2026-05-21	BSX	57.15	0.35	0.19	406832
2026-05-22	BSX	57.76	0.35	1.24	409394
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-24	BSX	62.06	11.0	1325.0	3.38
2026-04-27	BSX	59.96	11.0	1332.9	3.38
2026-04-28	BSX	58.44	11.0	1375.8	3.38
2026-04-30	BSX	57.61	11.0	1455.7	3.38
2026-05-01	BSX	56.51	11.0	1330.3	3.38
2026-05-04	BSX	56.85	11.0	1441.7	3.38
2026-05-05	BSX	55.97	11.0	981.4	3.38
2026-05-06	BSX	56.01	11.0	1057.2	3.38
2026-05-07	BSX	56.58	11.0	1101.3	3.38
2026-05-08	BSX	53.92	11.0	837.2	3.38
2026-05-11	BSX	53.37	11.0	1005.7	3.38
2026-05-12	BSX	54.13	11.0	1118.9	3.38
2026-05-13	BSX	53.03	11.0	962.0	3.38
2026-05-14	BSX	53.56	11.0	1096.8	3.38
2026-05-15	BSX	52.67	11.0	978.3	3.38
2026-05-18	BSX	55.94	11.0	1338.0	3.38
2026-05-19	BSX	56.83	11.0	1126.1	3.38
2026-05-20	BSX	56.67	11.0	1042.1	3.38
2026-05-21	BSX	57.14	11.0	1091.8	3.38
2026-05-22	BSX	57.78	11.0	1104.5	3.38
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-24	BSX	-4.42	0.27	1.59
2026-04-27	BSX	-4.42	0.40	1.73
2026-04-28	BSX	-3.18	0.40	1.73
2026-04-29	BSX	-3.03	0.40	1.73
2026-04-30	BSX	-3.03	0.40	1.73
2026-05-01	BSX	-3.03	0.40	1.73
2026-05-04	BSX	-3.03	0.39	1.73
2026-05-05	BSX	-2.41	0.39	1.73
2026-05-06	BSX	-2.41	0.39	1.73
2026-05-07	BSX	-2.25	0.39	1.73
2026-05-08	BSX	-2.25	0.39	1.73
2026-05-11	BSX	-2.25	-2.10	1.73
2026-05-12	BSX	-2.25	-2.10	1.94
2026-05-13	BSX	-2.25	-2.10	1.94
2026-05-14	BSX	-2.25	-2.10	1.94
2026-05-15	BSX	-2.25	-2.10	1.94
2026-05-18	BSX	-2.25	-1.86	1.94
2026-05-19	BSX	-2.13	-1.86	1.94
2026-05-20	BSX	-2.13	-1.86	1.94
2026-05-21	BSX	-2.13	-1.86	1.94
2026-05-22	BSX	-2.02	-1.86	1.94
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.8

Avg. EPS Est. Current Quarter

0.83

Avg. EPS Est. Next Quarter

0.85

Insider Transactions

-2.02

Institutional Transactions

-1.86

Beta

0.62

Average Sales Estimate Current Quarter

5396

Average Sales Estimate Next Quarter

5414

Fair Value

65.19

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

47.2

Max Drawdown 5-Year %

-51.3

Target Price

83.73

P/E

24.22

Forward P/E

15.33

PEG

1.34

P/S

4.16

P/B

3.32

P/Free Cash Flow

24.7

EPS

2.38

Average EPS Est. Cur. Y

3.38

EPS Next Y. (Est.)

3.76

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.29

Relative Volume

0.69

Return on Equity vs Sector %

-13.3

Return on Equity vs Industry %

1.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.08

EBIT Estimation

1104.5

◆ BSX Healthcare

$57.75

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

17/25

Volume

9/15

Valuation

18/20

TP/AR

2/10

Options

5/10

RSI

49.2

Range 1M

34.7%

Sup Dist

2.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

17/30

Estimates

6/20

Inst/Vol

0/15

Options

6/10

EPS Yr

10.5%

EPS NY

11.4%

52W%

8.7%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +34.5% upside

Quality

15/30

Valuation

13/30

Growth

12/25

Stability

6/10

LT Trend

1/5

Upside

+34.5%

Quality

MoS

13%

Boston Scientific Corporation

Sector: Healthcare

Industry: Medical Devices

Employees: 59000

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

BSX

Latest News

—

Caricamento notizie per BSX…

stock quote shares BSX – Boston Scientific Corporation Stock Price stock today

news today BSX – Boston Scientific Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch BSX – Boston Scientific Corporation yahoo finance google finance

stock history BSX – Boston Scientific Corporation invest stock market

stock prices BSX premarket after hours

ticker BSX fair value insiders trading

BSX – Boston Scientific Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: BSX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y